Citigroup Lowers Healthpeak Properties (NYSE:DOC) Price Target to $17.50

Healthpeak Properties (NYSE:DOCGet Free Report) had its price objective decreased by equities researchers at Citigroup from $18.00 to $17.50 in a research note issued on Wednesday,Benzinga reports. The firm currently has a “neutral” rating on the real estate investment trust’s stock. Citigroup’s price objective points to a potential upside of 6.66% from the stock’s current price.

DOC has been the topic of several other reports. Wall Street Zen lowered shares of Healthpeak Properties from a “hold” rating to a “sell” rating in a research report on Saturday. Argus cut shares of Healthpeak Properties from a “buy” rating to a “hold” rating in a research note on Thursday, February 5th. Weiss Ratings raised shares of Healthpeak Properties from a “sell (d+)” rating to a “hold (c-)” rating in a report on Monday, January 26th. Cantor Fitzgerald set a $17.00 target price on shares of Healthpeak Properties in a research report on Monday, January 5th. Finally, Jefferies Financial Group cut shares of Healthpeak Properties from a “buy” rating to a “hold” rating and dropped their target price for the company from $21.00 to $17.00 in a report on Monday, December 15th. Six equities research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company’s stock. According to MarketBeat.com, Healthpeak Properties currently has an average rating of “Hold” and an average target price of $19.27.

Get Our Latest Research Report on DOC

Healthpeak Properties Price Performance

Shares of DOC traded down $0.02 during mid-day trading on Wednesday, hitting $16.41. The company’s stock had a trading volume of 11,527,826 shares, compared to its average volume of 9,354,226. The company has a current ratio of 2.82, a quick ratio of 2.82 and a debt-to-equity ratio of 1.21. The firm has a 50-day simple moving average of $17.16 and a 200 day simple moving average of $17.48. The firm has a market capitalization of $11.41 billion, a P/E ratio of 164.09, a P/E/G ratio of 8.86 and a beta of 1.11. Healthpeak Properties has a 1-year low of $15.71 and a 1-year high of $20.10.

Healthpeak Properties (NYSE:DOCGet Free Report) last announced its quarterly earnings data on Monday, February 2nd. The real estate investment trust reported $0.47 earnings per share for the quarter, topping analysts’ consensus estimates of $0.45 by $0.02. The firm had revenue of $719.40 million for the quarter, compared to analyst estimates of $685.14 million. Healthpeak Properties had a return on equity of 0.84% and a net margin of 2.52%.Healthpeak Properties’s quarterly revenue was up 3.1% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.700-1.740 EPS. Analysts predict that Healthpeak Properties will post 1.86 EPS for the current fiscal year.

Hedge Funds Weigh In On Healthpeak Properties

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in DOC. Purpose Unlimited Inc. acquired a new stake in shares of Healthpeak Properties in the fourth quarter valued at approximately $451,000. Hsbc Holdings PLC raised its position in shares of Healthpeak Properties by 7.1% during the 4th quarter. Hsbc Holdings PLC now owns 3,262,602 shares of the real estate investment trust’s stock worth $52,462,000 after purchasing an additional 217,394 shares during the last quarter. Rockefeller Capital Management L.P. lifted its stake in Healthpeak Properties by 1.7% in the 4th quarter. Rockefeller Capital Management L.P. now owns 185,118 shares of the real estate investment trust’s stock valued at $2,977,000 after buying an additional 3,025 shares in the last quarter. Advisortrust Partners LLC purchased a new stake in Healthpeak Properties in the 4th quarter valued at approximately $388,000. Finally, Corient Private Wealth LLC grew its holdings in Healthpeak Properties by 3.5% during the 4th quarter. Corient Private Wealth LLC now owns 70,256 shares of the real estate investment trust’s stock valued at $1,130,000 after buying an additional 2,376 shares during the last quarter. Institutional investors and hedge funds own 93.57% of the company’s stock.

Healthpeak Properties Company Profile

(Get Free Report)

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.

Read More

Analyst Recommendations for Healthpeak Properties (NYSE:DOC)

Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.